The protein-based vaccine, after two Phase III clinical trials involving over 3,000 participants, was found to be safe, at least 90% effective in preventing symptomatic cases of the original coronavirus strain, and at least 80% effective in preventing symptomatic cases of the delta variant.
The vaccine will be deployed in other underserved countries following India, according to a news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
